GNC comparable store sales jump 16% in 2nd quarter; P&G, Menley report results.
This article was originally published in The Tan Sheet
GNC COMPARABLE-STORE SALES GREW 16.2% IN THE SECOND QUARTER while franchise comparable-store sales increased 19.3% during the three-month period ended July 22, the dietary supplement retailer announced Aug. 8. General Nutrition Companies reported that the comparable-store performance was "driven primarily by the continued demand for all supplement categories (vitamins, herbs and sports nutrition products) and further expansion of the company's Gold Card program" -- a membership program that entitles enrollees to once-a-month discounts
You may also be interested in...
Cosmetics Europe Talks Microplastic: ECHA Frustrations, ‘Value Judgments’ And International Trade Uncertainty
The European Chemicals Agency's microplastic restriction proposal received committee backing in 2020 without changes sought by the cosmetics industry, which faces €15bn in projected costs and scarce alternatives at present. It may come down to EU Member States to decide whether the ECHA restriction proposal is proportionate in balancing environmental goals and socio-economic impacts.
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.